Synthesis, anti-proliferation, apoptosis induction in breast cancer cells, and aromatase inhibition of coumarin-triazole hybrids: In vitro and in silico studies

dc.contributor.authorSaekee A.
dc.contributor.authorSooknual P.
dc.contributor.authorPunpai S.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorHongthong S.
dc.contributor.authorTanechpongtamb W.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorPingaew R.
dc.contributor.correspondenceSaekee A.
dc.contributor.otherMahidol University
dc.date.accessioned2025-02-05T18:29:33Z
dc.date.available2025-02-05T18:29:33Z
dc.date.issued2025-03-01
dc.description.abstractBreast cancer is one of the most common cancers found in women worldwide. Besides the availability of clinical drugs, drug resistance and considerable side effects are concerning issues driven the needs for the discovery of novel anticancer agents. Aromatase inhibition is one of the effective strategies for management of hormone-dependent breast cancer. Triazole, coumarin, and isatin are heterocyclic scaffolds holding great attention in the field of drug design. Molecular hybridization is a well-known strategy to achieve new molecules with improved potency and properties. Herein, a set of 27 triazole-based hybrids (i.e., coumarin-triazoles series 5–6 and isatin-triazoles series 7) were synthesized and investigated for their anti-proliferation, apoptosis induction, and aromatase inhibitory potentials. Anti-proliferative study against the hormone-dependent breast cancer (T47D) cell line indicated that coumarin-triazoles 5h (R=NO2) and 6i (R=SO2NH2) were the two most potent antiproliferative agents. Particularly, compound 5h showed comparable potency and superior selectivity index than that of the reference drug, doxorubicin. Moreover, the coumarin-triazole 5h induced cellular apoptosis of the estrogen-dependent breast cancer (MCF-7) cells. Additionally, findings from the aromatase inhibitory assay suggested four compounds as potential aromatase inhibitors (i.e., 5i, 6f, 6g and 6i, IC50 = 1.4–2.4 μM). Two QSAR models with preferable predictive performances were constructed to reveal key properties influencing antiproliferative and aromatase inhibitory effects. Molecular docking was conducted to elucidate the possible binding modalities against the target aromatase enzyme. Key structural features essential for the binding were highlighted. Moreover, the drug-like properties of top-ranking compounds were assessed to ensure their possibilities for successful development.
dc.identifier.citationArchives of Biochemistry and Biophysics Vol.765 (2025)
dc.identifier.doi10.1016/j.abb.2025.110308
dc.identifier.eissn10960384
dc.identifier.issn00039861
dc.identifier.scopus2-s2.0-85216197338
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/104181
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.titleSynthesis, anti-proliferation, apoptosis induction in breast cancer cells, and aromatase inhibition of coumarin-triazole hybrids: In vitro and in silico studies
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85216197338&origin=inward
oaire.citation.titleArchives of Biochemistry and Biophysics
oaire.citation.volume765
oairecerif.author.affiliationLaboratory of Medicinal Chemistry
oairecerif.author.affiliationChulabhorn Graduate Institute
oairecerif.author.affiliationFaculty of Science, Mahidol University
oairecerif.author.affiliationRajabhat Rajanagarindra University
oairecerif.author.affiliationThailand Ministry of Education
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationFaculty of Medicine, Srinakharinwirot University
oairecerif.author.affiliationSrinakharinwirot University

Files

Collections